New device could save
millions from septic shock
Send a link to a friend
[September 11, 2015] By
Ben Gruber
Boston, Mass. (Reuters) - Prostate cancer,
breast cancer and AIDS are all potentially lethal diseases that affect
hundreds of thousands each year. But Sepsis, a deadly immune response
triggered by infection, kills more people than all of them combined.
|
According to the National Institutes of Health, more than a million
people suffer from sepsis each year in the United States and between
30-50 percent die from the condition.
Mike Super says there is no approved therapy for sepsis, which is
why he and a team of scientists at Harvard's Wyss Institute are
attempting to develop one.
"The current standard of therapy is to give antibiotics and fluids.
But what we are talking about here is treatment for sepsis and that
is what is missing," said Super, a senior staff scientist at
Harvard's Wyss Institute.
According to Super, what is missing is a way to rapidly cleanse the
bloodstream of dangerous pathogens before they trigger a deadly
inflammatory response that could damage blood vessels and lead to
organ failure.
The scientists are using a dialysis system to filter the blood
through a tube filled with mesh of tiny fibers that are coated with
Super's secret weapon - an engineered protein called fcMBL.
"What's nice about proteins like this fcMBL from the innate immune
system is that they bind the sugars which are part of the cell wall
of the pathogens. They bind to the cell wall of bacteria, of fungi,
of many viruses and many parasites and they bind to toxins as well,"
Super said.
[to top of second column] |
"We are coating the inside of the tubes with that protein and we are
running the infected blood from the patient through that, through
the filter and binding, absorbing, capturing the pathogens that are
in that blood so that the blood that is going back to the patient is
cleansed," he added.
The patients right now are large animal models and rat models before
that. In the rat trials, the system was more than 99 percent
effective in filtering out deadly bacteria.
The researchers hope to start human trials in the near future. The
next step towards developing an effective treatment for one of the
world's leading killers.
[© 2015 Thomson Reuters. All rights
reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|